Logo image of CAVEN.OL

CAVENDISH HYDROGEN ASA (CAVEN.OL) Stock Fundamental Analysis

OSL:CAVEN - Euronext Oslo - NO0013219535 - Common Stock - Currency: NOK

7.8  +0.78 (+11.11%)

Fundamental Rating

3

Taking everything into account, CAVEN scores 3 out of 10 in our fundamental rating. CAVEN was compared to 54 industry peers in the Electrical Equipment industry. While CAVEN seems to be doing ok healthwise, there are quite some concerns on its profitability. CAVEN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CAVEN had negative earnings in the past year.
In the past year CAVEN has reported a negative cash flow from operations.
CAVEN.OL Yearly Net Income VS EBIT VS OCF VS FCFCAVEN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

CAVEN has a Return On Assets of -23.77%. This is amonst the worse of the industry: CAVEN underperforms 85.19% of its industry peers.
With a Return On Equity value of -30.99%, CAVEN is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -23.77%
ROE -30.99%
ROIC N/A
ROA(3y)-52.23%
ROA(5y)N/A
ROE(3y)-492.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CAVEN.OL Yearly ROA, ROE, ROICCAVEN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

With a decent Gross Margin value of 51.50%, CAVEN is doing good in the industry, outperforming 68.52% of the companies in the same industry.
CAVEN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CAVEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.14%
GM growth 5YN/A
CAVEN.OL Yearly Profit, Operating, Gross MarginsCAVEN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

CAVEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CAVEN remains at a similar level compared to 1 year ago.
Compared to 1 year ago, CAVEN has an improved debt to assets ratio.
CAVEN.OL Yearly Shares OutstandingCAVEN.OL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
CAVEN.OL Yearly Total Debt VS Total AssetsCAVEN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

A Debt/Equity ratio of 0.03 indicates that CAVEN is not too dependend on debt financing.
The Debt to Equity ratio of CAVEN (0.03) is better than 94.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.99%
CAVEN.OL Yearly LT Debt VS Equity VS FCFCAVEN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

CAVEN has a Current Ratio of 3.97. This indicates that CAVEN is financially healthy and has no problem in meeting its short term obligations.
CAVEN's Current ratio of 3.97 is amongst the best of the industry. CAVEN outperforms 96.30% of its industry peers.
CAVEN has a Quick Ratio of 2.92. This indicates that CAVEN is financially healthy and has no problem in meeting its short term obligations.
CAVEN's Quick ratio of 2.92 is amongst the best of the industry. CAVEN outperforms 94.44% of its industry peers.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 2.92
CAVEN.OL Yearly Current Assets VS Current LiabilitesCAVEN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

CAVEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.38%, which is quite impressive.
CAVEN shows a small growth in Revenue. In the last year, the Revenue has grown by 7.31%.
CAVEN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.24% yearly.
EPS 1Y (TTM)21.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.1%
Revenue 1Y (TTM)7.31%
Revenue growth 3Y-0.24%
Revenue growth 5YN/A
Sales Q2Q%-77.84%

3.2 Future

Based on estimates for the next years, CAVEN will show a very strong growth in Earnings Per Share. The EPS will grow by 24.53% on average per year.
CAVEN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 41.42% yearly.
EPS Next Y1.45%
EPS Next 2Y24.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.93%
Revenue Next 2Y41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CAVEN.OL Yearly Revenue VS EstimatesCAVEN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
CAVEN.OL Yearly EPS VS EstimatesCAVEN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CAVEN. In the last year negative earnings were reported.
Also next year CAVEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CAVEN.OL Price Earnings VS Forward Price EarningsCAVEN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAVEN.OL Per share dataCAVEN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

CAVEN's earnings are expected to grow with 24.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.53%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CAVEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAVENDISH HYDROGEN ASA

OSL:CAVEN (5/2/2025, 7:00:00 PM)

7.8

+0.78 (+11.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-28 2024-11-28/bmo
Earnings (Next)N/A N/A
Inst Owners8.63%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap262.24M
Analysts86.67
Price Target18.02 (131.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.58%
Min Revenue beat(2)-30.83%
Max Revenue beat(2)-22.33%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)88.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.72
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB 0.37
EV/EBITDA N/A
EPS(TTM)-7.96
EYN/A
EPS(NY)-8.27
Fwd EYN/A
FCF(TTM)-11.17
FCFYN/A
OCF(TTM)-8.47
OCFYN/A
SpS10.89
BVpS25.68
TBVpS21.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.77%
ROE -30.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.5%
FCFM N/A
ROA(3y)-52.23%
ROA(5y)N/A
ROE(3y)-492.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.14%
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 167.39%
Cap/Sales 24.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.97
Quick Ratio 2.92
Altman-Z N/A
F-Score3
WACC6.99%
ROIC/WACCN/A
Cap/Depr(3y)90.31%
Cap/Depr(5y)N/A
Cap/Sales(3y)21.12%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.1%
EPS Next Y1.45%
EPS Next 2Y24.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.31%
Revenue growth 3Y-0.24%
Revenue growth 5YN/A
Sales Q2Q%-77.84%
Revenue Next Year25.93%
Revenue Next 2Y41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-448.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.15%
OCF growth 3YN/A
OCF growth 5YN/A